Cite
Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using miR-15a-5p
MLA
Rui Qiu, and Zhifeng Zeng. “Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using MiR-15a-5p.” Canadian Journal of Gastroenterology and Hepatology, vol. 2022, Jan. 2022. EBSCOhost, https://doi.org/10.1155/2022/1206134.
APA
Rui Qiu, & Zhifeng Zeng. (2022). Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using miR-15a-5p. Canadian Journal of Gastroenterology and Hepatology, 2022. https://doi.org/10.1155/2022/1206134
Chicago
Rui Qiu, and Zhifeng Zeng. 2022. “Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using MiR-15a-5p.” Canadian Journal of Gastroenterology and Hepatology 2022 (January). doi:10.1155/2022/1206134.